IP Library Granted Patent US 7,951,941
Granted Patent B2
US 7,951,941 · App. 11/876,051 · Granted May 31, 2011

Process for preparing 5-alkyl-7H-pyrrolo[2,3-d] pyrimindine-2-ols

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,951,941
App. No.
11/876,051
Granted
May 31, 2011
Kind
B2
Abstract

Methods of preparing 5-alkyl-7H-pyrrolo[2,3-d]pyrimidin-4-ols are described, as are novel compounds useful in their preparation. A specific method encompassed by the invention is represented in the following scheme:

Claims (39)

1. A method of preparing a compound of formula I:

or a salt thereof, which comprises contacting a compound of formula II:

with a compound of formula HCOOR 5 under basic conditions sufficient to provide the compound of formula I, wherein:

R 1 is hydrogen or optionally substituted alkyl, aryl, heterocycle, arylalkyl, or heterocycloalkyl; and

R 5 is optionally substituted alkyl, aryl, or arylalkyl.

2. The method of claim 1 , wherein the compound of formula II is prepared by contacting a compound of formula III:

with cyanoacetamide under conditions sufficient to provide the compound of formula II, wherein:

R 2 and R 3 are each independently hydrogen or R 4 CO—, or are taken together with the nitrogen atom to which they are attached to provide a heterocycle; and

R 4 is optionally substituted alkyl, aryl, arylalkyl, alkoxy, or aryloxy.

3. The method of claim 1 , wherein the basic conditions are afforded by a base in a solvent.

4. The method of claim 3 , wherein the base is a metal hydroxide, metal alkoxide, metal amide, or mixture thereof.

5. The method of claim 4 , wherein the metal hydroxide is lithium hydroxide, sodium hydroxide, or potassium hydroxide.

6. The method of claim 4 , wherein the metal alkoxide is lithium methoxide, sodium methoxide, or sodium ethoxide.

7. The method of claim 4 , wherein the metal amide is lithium hexamethyldisilazide.

8. The method of claim 3 , wherein the solvent is an alcohol, amide, ether, nitrile, or mixture thereof.

9. The method of claim 8 , wherein the alcohol is methanol or ethanol.

10. The method of claim 8 , wherein the amide is dimethylformamide, dimethylacetamide, or N-methylpyrrolidone.

11. The method of claim 8 , wherein the ether is tetrahydrofuran, dioxane, or dimethoxyethane.

12. The method of claim 8 , wherein the nitrile is acetonitrile.

13. The method of claim 8 , wherein the solvent comprises methanol and dimethylformamide.

14. The method of claim 2 , wherein the conditions sufficient to provide the compound of formula II comprise a base in a solvent.

15. The method of claim 14 , wherein the base is a metal hydroxide, metal alkoxide, metal amide, or mixture thereof.

16. The method of claim 15 , wherein the metal hydroxide is lithium hydroxide, sodium hydroxide, or potassium hydroxide.

17. The method of claim 15 , wherein the metal alkoxide is lithium methoxide, sodium methoxide, or sodium ethoxide.

18. The method of claim 15 , wherein the metal amide is lithium hexamethyldisilazide.

19. The method of claim 14 , wherein the solvent is an alcohol, amide, ether, nitrile, or mixture thereof.

20. The method of claim 19 , wherein the alcohol is methanol or ethanol.

21. The method of claim 19 , wherein the amide is dimethylformamide, dimethylacetamide, or N-methylpyrrolidone.

22. The method of claim 19 , wherein the ether is tetrahydrofuran, dioxane, or dimethoxyethane.

23. The method of claim 19 , wherein the nitrile is acetonitrile.

24. The method of claim 19 , wherein the solvent comprises methanol and dimethylformamide.

25. The method of claim 1 , wherein R 1 is hydrogen.

26. The method of claim 1 , wherein R 1 is lower alkyl.

27. The method of claim 2 , wherein R 2 is hydrogen.

28. The method of claim 2 , wherein R 3 is R 4 CO—.

29. The method of claim 28 , wherein R 4 is alkyl or aryl.

30. The method of claim 2 , wherein R 2 and R 3 taken together with the nitrogen atom to which they are attached form phthalimido or succinimido.

31. The method of claim 1 , wherein R 5 is lower alkyl or phenyl.

32. The method of claim 31 , wherein R 5 is ethyl.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded May 5, 2026
From: OXFORD FINANCE LLC
To: LEXICON PHARMACEUTICALS, INC.; LEXICON PHARMACEUTICALS
Reel/Frame 075545/0601 →
SECURITY INTEREST Recorded May 4, 2026
From: LEXICON PHARMACEUTICALS, INC.; LEXICON PHARMACEUTICALS (NEW JERSEY), INC.; LION ACQUISITION CORPORATION
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 075498/0899 →
SECURITY INTEREST Recorded Mar 17, 2022
From: LEXICON PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 059432/0709 →
RELEASE OF SECURITY INTEREST Recorded Sep 14, 2020
From: BIOPHARMA CREDIT PLC
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 053767/0445 →
SECURITY INTEREST Recorded Dec 20, 2017
From: LEXICON PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 044958/0377 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2007
From: BEDNARZ, MARK S; KANAMARLAPUDI, RAMANAIAH C; WU, WENXUE
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 020082/0893 →